Fig. 2
From: LncRNA SNHG16 contributes to osteosarcoma progression by acting as a ceRNA of miR-1285-3p
SNHG16 enhanced OS cells proliferation in vitro, (A) (D) The relative expression of SNHG16 in negative control and SNHG16 silenced MNNG (or U2OS) cells. (B) (E) The cell growth rates were determined by performing CCK-8 assay. Knockdown SNHG16 in MNNG (or U2OS) cells suppressed cell proliferation. (C) (F) Colony formation assay of control and SNHG16 silenced MNNG (or U2OS) cells. Representative graphs are shown. Results are shown as mean ± SD;*P<0.05 (ANOVA)